Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.74%589.02M | 44.26%3.29B | -3.36%504.9M | -18.31%513.15M | 0.00%2.28B | 522.45M | 3.09%628.2M | -5.43%561.44M | 8.13%562.35M | 32.06%2.28B |
| Cost of revenue | 4.24%451.1M | 47.54%2.79B | 20.27%530.53M | -15.19%426.39M | 0.00%1.89B | 441.12M | 0.22%502.74M | -6.50%448.34M | 6.43%432.75M | 35.84%1.89B |
| Gross profit | 6.41%137.92M | 28.24%496.79M | -131.52%-25.63M | -30.84%86.76M | 0.00%387.4M | 81.33M | 16.45%125.46M | -0.94%113.11M | 14.23%129.61M | 16.27%387.4M |
| Operating expense | -11.90%89.74M | -7.89%353.39M | 22.57%109.57M | -15.09%79.52M | 29.98%383.66M | 89.39M | 5.11%93.65M | -3.26%87.9M | 18.61%101.86M | 54.94%295.17M |
| Selling and administrative expenses | -11.90%89.74M | 44.17%553.13M | 22.57%109.57M | -15.09%79.52M | 0.13%383.66M | --89.39M | 5.11%93.65M | -3.26%87.9M | 18.61%101.86M | 13.47%383.17M |
| -Selling and marketing expense | ---- | --5.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 27.03%4.61M |
| -General and administrative expense | -11.90%89.74M | 42.68%547.39M | 22.57%109.57M | -15.09%79.52M | 1.35%383.66M | --89.39M | 5.11%93.65M | -3.26%87.9M | 18.61%101.86M | 13.32%378.56M |
| Other operating expenses | ---- | ---816K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 111.89%348K |
| Total other operating income | ---- | --198.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -38.75%88.35M |
| Operating profit | 73.64%48.18M | 3,738.25%143.4M | -1,578.02%-135.2M | -77.23%7.24M | -95.95%3.74M | -8.06M | 70.68%31.81M | 8.13%25.2M | 0.59%27.75M | -35.36%92.23M |
| Net non-operating interest income (expenses) | 47.12%-5.8M | -447.77%-67.81M | 8.86%-9.57M | 15.98%-9.29M | 0.00%-12.38M | -10.5M | -482.97%-11.06M | -468.51%-15.4M | -157.63%-10.98M | 3.64%-12.38M |
| Non-operating interest income | -0.58%14.88M | 63.24%97.58M | -1.38%16.39M | -6.39%15.56M | 0.00%59.78M | --16.61M | 9.23%16.62M | 16.44%17.23M | 4.31%14.97M | -4.23%59.78M |
| Non-operating interest expense | -20.27%20.69M | -9.63%65.21M | -4.28%25.96M | -10.22%24.85M | 489.20%72.16M | --27.12M | 61.74%27.68M | 86.39%32.63M | 39.41%25.95M | -29.99%12.25M |
| Total other finance cost | ---- | --100.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.70%59.91M |
| Net investment income | 22.92M | 1,394.38%19.94M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | 2.53M | 0 | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 11.03%5.68M | 82.50%32.32M | 22.92%5.63M | 0.33%5.79M | 0.00%17.71M | 4.58M | 37.87%5.77M | 4.68%5.43M | 35.96%5.12M | 12.97%17.71M |
| Special income (charges) | 4.17M | -52.77%3.28M | ||||||||
| Less:Impairment of capital assets | ---- | ---489K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Less:Other special charges | ---- | ---1.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.09%-3.2M |
| Less:Write off | ---- | ---2.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---73K |
| Other non-operating income (expenses) | -68.85%4.18M | -94.69%7.37M | 272.65%160.3M | -5.90%3.4M | 412.76%138.77M | 43.02M | -61.39%3.61M | -23.26%10.74M | 230.74%13.42M | -45.50%27.06M |
| Income before tax | 47.96%52.24M | -1.98%144.91M | -27.12%21.16M | -76.30%7.14M | 0.00%147.84M | 29.04M | -0.49%30.14M | -34.71%25.98M | 13.36%35.3M | -27.33%147.84M |
| Income tax | 42.92%15.86M | 1.19%50.8M | -72.78%4.48M | 255.84%5.85M | 0.00%50.2M | 16.46M | -84.65%1.64M | -2.48%16.07M | 8.82%11.1M | -18.01%50.2M |
| Net income | 50.27%36.38M | -3.60%94.12M | 32.60%16.68M | -95.46%1.29M | 0.00%97.64M | 12.58M | 45.55%28.49M | -57.50%9.91M | 15.57%24.21M | -31.35%97.64M |
| Net income continuous operations | 50.27%36.38M | -3.60%94.12M | 32.60%16.68M | -95.46%1.29M | 0.00%97.64M | --12.58M | 45.55%28.49M | -57.50%9.91M | 15.57%24.21M | -31.35%97.64M |
| Noncontrolling interests | -52.90%6.53M | -58.84%18.44M | 79.20%-1.09M | -146.34%-5.65M | 0.00%44.81M | -5.24M | 30.39%12.19M | -70.00%3.38M | 41.06%13.86M | -4.59%44.81M |
| Net income attributable to the company | 188.50%29.85M | 43.24%75.68M | -0.25%17.77M | -57.40%6.94M | 0.00%52.83M | 17.82M | 59.41%16.3M | -45.83%6.53M | -6.95%10.35M | -44.54%52.83M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 188.50%29.85M | 43.24%75.68M | -0.25%17.77M | -57.40%6.94M | 0.00%52.83M | 17.82M | 59.41%16.3M | -45.83%6.53M | -6.95%10.35M | -44.54%52.83M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 188.94%0.023 | 42.44%0.0584 | 0.00%0.0137 | -57.14%0.0054 | 0.00%0.041 | 0.0137 | 59.49%0.0126 | -46.81%0.005 | -6.98%0.008 | -44.24%0.041 |
| Diluted earnings per share | 188.94%0.023 | 42.44%0.0584 | 0.00%0.0137 | -57.14%0.0054 | 0.00%0.041 | 0.0137 | 59.49%0.0126 | -46.24%0.005 | -6.98%0.008 | -44.09%0.041 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 600.02%0.0348 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.